COEP
$11.06
Pre-MarketAs of Mar 23, 8:00 PM UTC
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$11.06
Potential Upside
5%
Whystock Fair Value$11.61
Price
UndervaluedFair ValueOvervalued
Fundamentals
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licen...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$68.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-119.52%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.21
